Posted on January 10, 2025 SOM Biotech will attend JP Morgan Healthcare Conference from January 13th to January 16th 2025
Posted on October 22, 2024 SOM Biotech participated in the last edition of Barcelona New Economy Week (BNEW)
Posted on October 15, 2024 SOM Biotech announces the presentation of the Phase2b study results in Huntington Chorea Patients at the HDG Conference in Cincinnati
Posted on July 25, 2024 SOM Biotech announces the database lock of its Phase2b study with SOM3355 in Huntington’s chorea patients and looks for top-line results in August.
Posted on June 19, 2024 The Brazilian Journal of Implantology and Health Sciences cites SOM3355 as a promising therapy for chorea in Huntington’s disease.
Posted on April 10, 2024 SOM Biotech announces the completion of recruitment in the Phase IIb study of the treatment of chorea in Huntington’s disease patients with SOM3355
